SOURCE: Zynex, Inc.

Zynex,  Inc.

May 07, 2014 08:30 ET

Zynex Schedules First Quarter 2014 Earnings Release and Webcast

LONE TREE, CO--(Marketwired - May 7, 2014) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host an investor webcast, Tuesday, May 13, 2014 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time to discuss the Company's first quarter 2014 results.

The Company expects to release first quarter results on Tuesday, May 13, 2014 prior to the market open.

Webcast Details: Tuesday, May 13, 2014 at 9:00 a.m. MT - 11:00 a.m. ET
To register and participate in the webcast, interested parties should click on the following link approximately 10-15 minutes prior to the webcast:
http://www.visualwebcaster.com/event.asp?id=99245

Please note: questions can only be submitted via the webcast user interface. Parties without access to the Internet may join the presentation in listen only mode by dialing the toll free number provided below.

Phone Access Details
Participant Toll Free Dial-in Number: 888-539-3678
Participant Phone Access Passcode: 8893871

About Zynex

Zynex, founded in 1996, operates under five primary business segments: Zynex Medical, NeuroDiagnostics, Monitoring Solutions, International, and Billing and Consulting. Zynex Medical engineers, manufactures, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex Medical's product lines are fully developed, FDA-cleared and commercially sold world-wide. Zynex Medical also operates a non-sterile compound pharmacy providing topical and transdermal pain creams. Zynex NeuroDiagnostics sells and distributes EMG, EEG, sleep pattern, auditory and nerve conductivity neurological devices. Zynex Monitoring Solutions, currently in the development stage, was established to develop and market medical devices for non-invasive cardiac monitoring. Zynex International is dedicated to supporting sales and marketing of Zynex products worldwide through a network of medical distributors. Zynex Billing and Consulting division provides medical billing and consulting service for offices and hospitals.

For additional information, please visit: www.ir-site.com/zynex

Safe Harbor Statement

Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage additional sales representatives, the success of such additional sales representatives, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement from insurance companies for products sold or rented to our customers, acceptance of our products by health insurance providers, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the uncertain outcome of pending material litigation and other risks described in our filings with the Securities and Exchange Commission including the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2013.

Contact Information

  • Contact:
    Zynex, Inc.
    Anthony Scalese
    CFO
    303-703-4906